Orasis Pharmaceuticals

Patent cliffs & loss of exclusivity

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Company

Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/orasis-pharmaceuticals
Email format{first}.{last}
Full Address12 Maskit St., Herzlyia, IL
LinkedIn URLhttps://www.linkedin.com/company/orasis-pharmaceuticals/
Public/PrivatePrivate
Seedtable URLhttps://seedtable.com/companies/orasis-pharmaceuticals
Twitter URLhttps://x.com/OrasisPharma

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. QLOSIPILOCARPINE HYDROCHLORIDESmall mol.Aug 2037

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.